![[spacer image]](../images/spacer_blue.gif)
 |
![[spacer image]](/images/spacer.gif) |
By shortening diagnosis time, the BD MGIT™ (Mycobacteria Growth Indicator Tube) system can help stop tuberculosis.
More Information »
|
|
|
|
|
| News & Events |
|
![[spacer image]](/images/spacer_gray.gif)
Becton Dickinson Completes Acquisition of Medical Devices Division of The BOC Group
|
|
Franklin Lakes, NJ
(April 03, 1998) --
Becton Dickinson and
Company (NYSE:BDX) announced today that it has completed its
acquisition of Ohmeda's Medical Devices Division from The BOC
Group. The purchase price for the transaction was $452 million
dollars. The acquisition will be part of Becton Dickinson's
worldwide infusion therapy business.
|
|
![[spacer image]](/images/shadow_top_left.gif){kind=small}
![[spacer image]](/images/shadow_top_right.gif){kind=small}
![[spacer image]](/images/shadow_left.gif){kind=small}
![[spacer image]](/images/spacer_blue.gif){kind=small}
![[spacer image]](/images/shadow_right.gif){kind=small}
![[spacer image]](/images/shadow_bottom_left.gif){kind=small}
![[spacer image]](/images/shadow_bottom.gif){kind=small}
![[spacer image]](/images/shadow_bottom_right.gif){kind=small}